Colgate-Palmolive CEO sells 20,000 shares

Colgate-Palmolive’s Chairman, President & CEO had 359,700 shares held directly after the sale.

Available on EDGAR 11/06/2026 - 04:07 PM EST Accepted by SEC EDGAR 11/06/2026 - 04:06 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Colgate-Palmolive (CL) Chairman, President & CEO Noel R. Wallace sold 20,000 common shares on November 5, 2026, at a weighted average price of $100.2581 per share. The shares were sold in multiple transactions at prices ranging from $100.01 to $100.51, inclusive. He held 359,700 shares directly after the sale. The report also lists indirect holdings of 55,173 shares by the issuer’s 401(k) plan trustee, 52,000 shares by a spouse trust and 335 shares by a trust.

Insider Trade Summary

Net Seller: 20,000 shares

Net Sell 1 txn

Insider Wallace Noel R.

Role Chairman, President & CEO

Sold 20,000 shs ($2.01M)

Type	Security	Shares	Price	Value
Sale	Common Stock F1	20,000	$100.2581	$2.01M
Holding	Common Stock	--	--	--
Holding	Common Stock	--	--	--
Holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 359,700 shares (Direct); Common Stock — 55,173 shares (Indirect, By Issuer's 401(k) Plan Trustee); Common Stock — 52,000 shares (Indirect, By Spouse Trust); Common Stock — 335 shares (Indirect, By Trust)

Footnotes (1)

1. F1. Weighted average price, as these shares were sold in multiple transactions at prices ranging from $100.01 to $100.51, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Key Figures

Shares sold: 20,000 shares Weighted average sale price: $100.2581 per share Direct shares following sale: 359,700 shares +3 more

6 metrics

Shares sold 20,000 shares November 5, 2026

Weighted average sale price $100.2581 per share November 5, 2026

Direct shares following sale 359,700 shares November 5, 2026

Shares by issuer’s 401(k) plan trustee 55,173 shares Indirect holding listed on November 5, 2026

Shares by spouse trust 52,000 shares Indirect holding listed on November 5, 2026

Shares by trust 335 shares Indirect holding listed on November 5, 2026

Key Terms

weighted average price, 401(k) Plan Trustee, issuer

3 terms

weighted average price financial

"Weighted average price, as these shares were sold"

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

401(k) Plan Trustee financial

"By Issuer's 401(k) Plan Trustee"

issuer regulatory

"security holder of the issuer"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many CL shares did Noel R. Wallace sell, and at what price?

Noel R. Wallace sold 20,000 Colgate-Palmolive common shares on November 5, 2026, at a weighted average of $100.2581 per share. The individual sale prices ranged from $100.01 to $100.51, inclusive.

How many CL shares did Noel R. Wallace hold after the sale?

Noel R. Wallace’s reported direct holdings were 359,700 shares after the sale. The report also lists indirect holdings of 55,173 shares by the issuer’s 401(k) plan trustee, 52,000 shares by a spouse trust and 335 shares by a trust.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wallace Noel R.

(Last) (First) (Middle)

C/O COLGATE-PALMOLIVE COMPANY

300 PARK AVENUE

(Street)

NEW YORK NEW YORK 10022

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
COLGATE PALMOLIVE CO [ CL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chairman, President & CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
11/05/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/05/2026		S		20,000	D	$100.2581(1)	359,700	D
Common Stock								55,173	I	By Issuer's 401(k) Plan Trustee
Common Stock								52,000	I	By Spouse Trust
Common Stock								335	I	By Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Weighted average price, as these shares were sold in multiple transactions at prices ranging from $100.01 to $100.51, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.

	/s/ Kristine Hutchinson, Attorney-in-Fact	11/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)